Beyond ObamaCare: Big Pharma, Health Reform and the 2012 Elections
This article was originally published in RPM Report
Executive Summary
Most everyone can agree that health care costs are spiraling out of control. President Obama and his Republican challenger Mitt Romney each say they have a plan to cut spending. But while those are being debated, a high-profile group of former Obama advisers are suggesting something much more radical: a systematic change in the way we pay for health care. Could it be a blueprint for a second Obama term?
You may also be interested in...
Betting and Winning: SCOTUS Decision Underscores High Stakes In Pharma’s Strategy
The Supreme Court decision was a decisive victory for the biopharma industry for a number of reasons. But the drama that unfolded in a razor-close decision will continue as new milestones—political and legislative—approach.
Part D Rebates Would Contribute More Than Half Of Medicare Savings In White House Plan
Plan seeks to cut Medicare costs by a total of $248 billion over 10 years, with mandatory rebates in Part D contributing $135 billion.
Hearings Show IPAB Has Little Support In House, But Does It Matter?
Two congressional hearings during the week of July 15 confirmed there is little support in the House for the Independent Payment Advisory Board and its broad power to make cost-cutting changes to Medicare.